1. CONSORT 2025 provides an update to the guidelines for reporting randomized trials, aiming to enhance transparency and completeness in reporting.
2. It consists of a 30-item checklist of essential items and addresses the suboptimal quality of reporting trial results.
3. It is a living guideline, which can be periodically updated to reflect new evidence and perspectives.
4. Implementation resources include an expanded checklist and a website to facilitate adoption.
5. CONSORT 2025 supersedes the previous statement from 2010 and should now be used by authors, editors, reviewers, and journal editors for writing and evaluating manuscripts of randomized trials.

Source: JAMA